Risk factors for early invasive fungal infections in paediatric liver transplant recipients

Keyphrases

• Risk Factors 100%
• Liver Transplant Recipients 100%
• Invasive Fungal Infection 100%
• Pediatric Liver Transplant 100%
• Early Invasive Strategy 100%
• Pretransplant 50%
• Predictive Models 33%
• First Month 33%
• Transplantation 33%
• Clinical High Risk 33%
• Antibiotic Treatment 33%
• IV Antibiotics 33%
• Pediatric Population 16%
• Significant Risk Factors 16%
• Independent Risk Factors 16%
• Stepwise Logistic Regression 16%
• Transplant Center 16%
• Clinical Parameters 16%
• All Pediatric 16%
• Area under the ROC Curve 16%
• Surgical Complications 16%
• Non-albicans Candida 16%
• Candida Species 16%
• Prolonged Use 16%
• Blood Product Transfusion 16%
• Antifungal Prophylaxis 16%
• Pulse Steroids 16%
• Living Donor Liver Transplantation 16%
• Living Donor Transplantation 16%
• Intravenous Catheter 16%

Medicine and Dentistry

• Pediatrics 100%
• Liver Graft 100%
• Systemic Mycosis 100%
• Antibiotic Therapy 33%
• Logistic Regression Analysis 16%
• Postoperative Complication 16%
• Infection 16%
• Steroid Treatment 16%
• Antifungal Agent 16%
• Liver Transplantation 16%
• Pulse Rate 16%
• Blood Product 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Systemic Mycosis 100%
• Antibiotics 33%
• Candida Albicans 16%
• Candida 16%
• Steroid Treatment 16%
• Postoperative Complication 16%
• Infection 16%
• Antifungal Agent 16%